↓ Skip to main content

Dove Medical Press

Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects

Overview of attention for article published in Drug Design, Development and Therapy, March 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent
4 patents

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
48 Mendeley
Title
Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects
Published in
Drug Design, Development and Therapy, March 2019
DOI 10.2147/dddt.s199051
Pubmed ID
Authors

Patricia N Sidharta, Meggane Melchior, Martin K Kankam, Jasper Dingemanse

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 13%
Student > Ph. D. Student 5 10%
Student > Doctoral Student 4 8%
Researcher 4 8%
Other 4 8%
Other 6 13%
Unknown 19 40%
Readers by discipline Count As %
Nursing and Health Professions 9 19%
Medicine and Dentistry 6 13%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Psychology 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 3 6%
Unknown 20 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2023.
All research outputs
#8,538,940
of 25,385,509 outputs
Outputs from Drug Design, Development and Therapy
#641
of 2,268 outputs
Outputs of similar age
#152,626
of 367,999 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 39 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,999 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.